Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ, Schuurman R, Visscher H, de Vos M, Bierings M, van Loon AM, Uiterwaal CS, van Baarle D, Sanders EA, Boelens J. de Pagter PJ, et al. Among authors: van loon am, van baarle d. Biol Blood Marrow Transplant. 2008 Jul;14(7):831-9. doi: 10.1016/j.bbmt.2008.04.016. Biol Blood Marrow Transplant. 2008. PMID: 18541204 Free article.
Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease.
Meij P, van Esser JW, Niesters HG, van Baarle D, Miedema F, Blake N, Rickinson AB, Leiner I, Pamer E, Lowenberg B, Cornelissen JJ, Gratama JW. Meij P, et al. Among authors: van esser jw, van baarle d. Blood. 2003 Jun 1;101(11):4290-7. doi: 10.1182/blood-2002-10-3001. Epub 2003 Feb 6. Blood. 2003. PMID: 12576337 Free article.
Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution.
Annels NE, Kalpoe JS, Bredius RG, Claas EC, Kroes AC, Hislop AD, van Baarle D, Egeler RM, van Tol MJ, Lankester AC. Annels NE, et al. Among authors: van tol mj, van baarle d. Clin Infect Dis. 2006 Jun 15;42(12):1743-8. doi: 10.1086/503838. Epub 2006 May 4. Clin Infect Dis. 2006. PMID: 16705581
Rituximab treatment before reduced-intensity conditioning transplantation associates with a decreased incidence of extensive chronic GVHD.
van Dorp S, Pietersma F, Wölfl M, Verdonck LF, Petersen EJ, Lokhorst HM, Martens E, Theobald M, van Baarle D, Meijer E, Kuball J. van Dorp S, et al. Among authors: van baarle d. Biol Blood Marrow Transplant. 2009 Jun;15(6):671-8. doi: 10.1016/j.bbmt.2009.02.005. Epub 2009 Apr 16. Biol Blood Marrow Transplant. 2009. PMID: 19450751 Free article.
T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency.
Haveman LM, Scherrenburg J, Maarschalk-Ellerbroek LJ, Hoek PD, Schuurman R, de Jager W, Ellerbroek PM, Prakken BJ, van Baarle D, van Montfrans JM. Haveman LM, et al. Among authors: van montfrans jm, van baarle d. Clin Exp Immunol. 2010 Jul 1;161(1):108-17. doi: 10.1111/j.1365-2249.2010.04159.x. Epub 2010 Apr 9. Clin Exp Immunol. 2010. PMID: 20408855 Free PMC article.
222 results